Goldman Sachs strategist: US healthcare stocks contain opportunities.

Goldman Sachs strategist indicated that the future prospects of the healthcare industry are looking good, especially when the artificial intelligence investment craze fades and investors further withdraw from technology stocks after underperforming the S&P 500 index in the past three years. Led by David Kostin, the Goldman Sachs strategy team wrote in a report that another scenario is that the continuous advancement and widespread application of artificial intelligence technology will ultimately help improve the profitability of the healthcare industry. Currently, the industry is trading at a discount relative to the S&P 500 index, nearing a historical record low valuation, which creates the potential for significant gains, but the strategist believes that the opportunity for earning excess returns is greater compared to the overall market volatility.